|
Neonatal Intensive Care Drug Manual
|
| bet | 383/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Adverse Reactions
|
Naloxone administered to babies whose mothers are known or suspected to be addicted to opioids may precipitate an acute withdrawal syndrome (tachycardia, tachypnoea, hypertension, tremors, vomiting and seizures).
Cardiac arrest – there is a case report of a preterm neonate who developed cardiac arrest. [18]
|
Compatibility
|
Fluids: Glucose 5%, sodium chloride 0.9%
Y-site: Defibrotide, linezolid
|
Incompatibility
|
Do not mix in an alkaline solution.Fluids: No information
Drugs: Solutions that contain bisulfites or sulfites , calcium folinate
|
Stability
|
Infusion solution: Use within 24 hours.
|
Storage
|
Ampoule and Min-I-Jet syringe: Store below 25°C. Protect from light. Do not freeze.
|
|
|
| |
